Multiresistant bacterial infections in liver cirrhosis: Clinical impact and new empirical antibiotic treatment policies

查看全文 作　　者：Juan [1]Acevedo

机构地区：[1]Department of Gastroenterology and Hepatology, Queen Alexandra Hospital

出　　处：《World Journal of Hepatology》索引2015年第7卷第7期,共6页

摘　　要：Recently, important changes have been reported regarding the epidemiology of bacterial infections in liver cirrhosis. There is an emergence of multiresistant bacteria in many European countries and also worldwide, including the United States and South Korea. The classic empirical antibiotic treatment(third-generation cephalosporins, e.g., ceftriaxone, cefotaxime or amoxicillin-clavulanic acid) is still effective in infections acquired in the community, but its failure rate in hospital acquired infections and in some health-care associated infections is high enough to ban its use in these settings. The current editorial focuses on the different epidemiology of bacterial infections in cirrhosis across countries and on its therapeutic implications. 关键词：细菌的感染 Multiresistant 细菌抗菌素肝肝硬化

相关文献

参考文献（42）
引证文献（8）
耦合文献（298）

参考文献(42)

引证文献(8)

耦合文献(298)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Multiresistant bacterial infections in liver cirrhosis: Clinical impact and new empirical antibiotic treatment policies

参考文献(42)

引证文献(8)

耦合文献(298)

用户提示